May 13, 2021 / 09:00PM GMT
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity Research
Good evening, everybody, and thanks for joining us at the Bank of America Annual Healthcare Conference being conducted virtually this year. Hopefully, next year -- the CDC just gave us the mask-free mandate. So hopefully, next year, we'll be able to do this in Las Vegas.
This is our final fireside chat of a 3-day event, and I'm pleased to be introducing our next company presenter, FibroGen and CEO Enrique Conterno. So Enrique, thanks for joining us.
Enrique A. Conterno - FibroGen, Inc. - CEO & Director
Jason, thank you very much for the invitation. I'm looking forward to the chat.
Questions and Answers:
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity ResearchYes. Maybe just kicking things off, maybe just talk a little bit about what drew you to FibroGen. You're coming from Eli Lilly, intimately involved in diabetes, large markets, the primary asset, roxadustat also being something
Trustpilot
